| Literature DB >> 30333946 |
Ben-Hong Xu1,2, Zhi-Wei Ye1,2, Qian-Wang Zheng1,2, Tao Wei1,2, Jun-Fang Lin1,2, Li-Qiong Guo1,2.
Abstract
In this research, the antimicrobial substance anti-JFL15 was partially purified using a simple two-step extraction process from the cell-free supernatants of Bacillus siamensis JFL15. Anti-JFL15 exhibited a strong antibacterial activity against various multidrug-resistant aquatic bacterial pathogens, including Escherichia coli, Edwardsiella tarda, Pseudomonas aeruginosa, Aeromonas hydrophila, and Vibrio. Liquid chromatography-mass spectrometry revealed that anti-JFL15 contained eight cyclic lipopeptides belonging to two families: bacillomycin F (m/z 1056.56-1084.59) and surfactin (m/z 1007.65-1049.70) analogs. PCR analysis showed the presence of genes (i.e., sfp gene, surfactin synthetase D, fengycin synthetase B, iturin synthetase A, iturin synthetase C and bacillomycin synthetase D) involved in the biosynthesis of cyclic lipopeptides. This study is the first to identify cyclic lipopeptides from B. siamensis and use them to suppress the growth of various multidrug-resistant aquatic bacterial pathogens. Results indicated that B. siamensis JFL15 is a promising biocontrol agent for the effective and environmentally friendly control of various multidrug-resistant aquatic bacterial pathogens.Entities:
Keywords: Antimicrobial activity; Bacillus siamensis; Cyclic lipopeptide; Multidrug-resistant aquatic bacterial pathogen; Pathogenic fungi
Year: 2018 PMID: 30333946 PMCID: PMC6175734 DOI: 10.1007/s13205-018-1443-4
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406